Pertuzumab is a monoclonal antibody that targets the human epidermal growth factor receptor 2 (HER2). It is commonly used in the treatment of HER2-positive breast cancer. By binding to the HER2 receptor, pertuzumab prevents its dimerization, thereby inhibiting cell proliferation and survival pathways.
